One chart explains why the UK pulled the AstraZeneca COVID-19 vaccine for under-30s

This chart shows the risk to benefit balance for the AstraZeneca vaccine in different populations, according to the UK's MHRA.

MHRA

• The UK is to offer alternatives to the AstraZeneca vaccine to under-30s over reports of blood clots.
• Officials say the "suspected" side effect is very rare, and vaccine benefits still outweigh risks.
• But they said the decision was made as young people face more risk of clots and less from COVID-19.
• The chart above, made by the UK Medicines and Healthcare products Regulatory Agency, shows this balance of risks.
• See more stories on Insider's business page.

Read the original article on Business Insider

from Business Insider https://ift.tt/31Y3aLg